Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke

Immunological Investigations

Volumn 38, Issue 3-4, 2009, Pages 220-230

  Rezaii, Ali Akbar ^a   Hoseinipanah, Seyed Mohamad ^b   Hajilooi, Mehrdad ^c   Rafiei, Ali Reza ^d   Shikh, Nasrin ^e   Haidari, Mehran ^f,g  

^a Sina Hospital Hamedan   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF TEXAS   (United States)

^g TEXAS HEART INSTITUTE   (United States)

Author keywords

Interleukin 1 receptor antagonist; Polymorphism; Stroke

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 70350635584     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130902745146     Document Type: Article

References (46)

1. Allan, S. M., Rothwell, N. J. (2001). Cytokines and acute neuroDegeneration. Nat. Rev. Neurosci. 2(10):734-744.
2. American Diabetes Association. (2005). Diagnosis and classification of Diabetes mellitus. Diabetes Care 28 (Suppl 1):S37-S42.
3. Arend, W. P., Malyak, M., Guthridge, C. J., Gabay, C. (1998). Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16:27-55.
4. Blakemore, A. I., Tarlow, J. K., Cork, M. J., Gordon, C., Emery, P., Duff, G. W. (1994). Interleukin-1 receptor antagonist gene polymorphism as a Disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37:1380-1385.
5. Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., Rothwell, N. J. (2001). Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 21:5528-5534.
6. Carter, M. J., Di Giovine, F. S., Jones, S., Mee, J., Camp, N. J., Lobo, A. J., et al. (2001). Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 48:461-467. (Pubitemid 32234788)
7. Carter, M. J., Jones, S., Camp, N. J., Cox, A., Mee, J., Warren, B., et al. (2004). Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun. 5:8-15.
8. Casas, J. P., Hingorani, A. D., Bautista, L. E., Sharma, P. (2004). Metaanalysis of genetics stuDies in ischemic stroke. Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol. 61:1652-1662.
9. Chamorro, A., Hallenbeck, J. (2006). The harms and benefits of inflammatory and immune responses in vascular Disease. Stroke 2006;37:291-293
10. Cork, M. J., Tarlow, J. K., Blakemore, A. I., McDonagh, J. G., Messenger, A. G., Bleehen, S. S., et al. (1993). Genetics of interleukin one receptor antagonists in inflammatory skin Diseases. J. Invest. Dermatol. 100:552.
11. Danis, V. A., Millington, M., Hyland, V. J., Grennan, D. (1995). Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1RA) gene polymorphism. Clin. Exp. Immunol. 99:303-310.
12. Decker, C. J., Parker, R. (1995). Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr. Opin. Cell Biol. 7(3):386-392.
13. Dewberry, R., HolDen, H., Crossman, D., Francis, S. (2000). Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20(11):2394-2400.
14. El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C. C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F. Jr., Rabkin, C. S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 Mar 23;404(6776):398-402.
15. Emsley, H. C., Smith, C. J., Georgiou, R. F., et al. (2005). A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psych. 76:1366-1372.
16. Emsley, H. C., Tyrrell, P. J. (2002). Inflammation and infection in clinical stroke. J. Cereb. Blood Flow Metab. 22(12):1399-1419.
17. Endler, G., Funk, M., Haering, D., et al. (2003). Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular Disease? Br. J. Haematol. 120:310-314.
18. Feigin, V. L., Lawes, C. M., Bennett, D. A., AnDerson, C. S. (2003). Stroke epiDemiology: a review of population-based stuDies of inciDence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2(1):43-53.
19. Francis, S. E., Camp, N. J., Dewberry, R. M., Gunn, J., Syrris, P., Carter, N. D., Jeffery, S., Kaski, J. C., Cumberland, D. C., Duff, G. W., Crossman, D. C. (1999). Interleukin-1 receptor antagonist gene polymorphism and coronary artery Disease. Circulation 23;99(7):861-866.
20. Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S. T., et al. (2003). The gene encoDing phosphoDiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35:131-138
21. Hassan, A., Markus, H. S. (2000). Genetics and ischemic stroke. Brain 123:1784-1812.
22. Jeffs, B., Clark, J. S., AnDerson, N. H., Gratton, J., Brosnan, M. J., Gauguier, D. et al. (1997). Sensitivity to cerebral ischaemic insult in a rat moDel of stroke is Determined by a single genetic locus. Nature Genet. 16:364-367.
23. Lai, J., Zhou, D., Xia, S., Shang, Y., Zhu, J., Pan, J., Hua, B., Zhu, Y., Cui, L. (2006). Association of interleukin-1 gene cluster polymorphisms with ischemic stroke in a Chinese population. Neurol InDia 54(4):366-369.
24. Lalouschek, W., Schillinger, M., Hsieh, K., Endler, G., Greisenegger, S., Marculescu, R., Lang, W., Wagner, O., Cheng, S., Mannhalter, C. (2006). Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin. Chem. Lab. Med. 44(8):918-923.
25. Lee, B. C., Ahn, S. Y., Doo, H. K., et al. (2004). Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci. Lett. 357:33-36.
26. Malyak, M., Smith, M. F. Jr., Abel, A. A., Hance, K. R., Arend, W. P. (1998). The Differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. J. Immunol. 161: 2004-2010.
27. Mandrup-Poulsen, T., Pociot, F., Molvig, J., Shapiro, L., Nilsson, P., Emdal, T., et al. (1994). Monokine antagonism is reduced in patients with IDDM. Diabetes 43:1242-1247.
28. Marculescu, R., Endler, G., Schillinger, M., Iordanova, N., Exner, M., HayDen, E., Huber, K., Wagner, O., Mannhalter, C. (2002). Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 Diabetes. Diabetes 51(12):3582-3585.
29. Markus, H. S., Labrum, R., BeVan, S., Reindl, M., Egger, G., WieDermann, C. J., Xu, Q., Kiechl, S., Willeit, J. (2006). Genetic and acquired inflammatory conDitions are synergistically associated with early carotid atherosclerosis. Stroke Sep;37(9): 2253-2259.
30. Meulenbelt, I., Seymour, A. B., Nieuwland, M., Huizinga, T. W., Van Duijn, C. M., Slagboom, P. E. (2004). Association of the interleukin-1 gene cluster with raDiographic signs of osteoarthritis of the hip. Arthritis Rheum. 50:1179-1186.
31. Miller SA, Dykes DD, Polesky HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215-1218.
32. Perrier, S., CousseDiere, C., Dubost, J. J., Albuisson, E., Sauvezie, B. (1998). IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin. Immunol. Immunopathol. 87:309-313.
33. Redlitz, K. H., Yamshchikov, V. F., Cominelli, F. (2004). Differential contribution of IL-1Ra isoforms to allele-specific IL-1Ra mRNA accumulation. J. Interferon Cytokine Res. 24:253-260.
34. Ross R. (1999). Atherosclerosis: an inflammatory Disease. N. Engl. J. Med. 340:115-126.
35. Schielke, G. P., Yang, G. Y., Shivers, B. D., Betz, A. L. (1998). Reduced ischemic brain injury in interleukin-1 beta converting enzyme-Deficient mice. J. Cereb. Blood Flow Metab. 18(2):180-185.
36. Seripa, D., Dobrina, A., Margaglione, M., et al. (2003). ReleVance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc. Dis. 15:276-281.
37. Stroemer, R. P., Rothwell, N. J. (1998). Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 beta in the rat. J. Cereb. Blood Flow Metab. 18(8):833-839.
38. Sun, L., Li, Z., Zhang, H., et al. (2003). PentanucleotiDe TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China. Stroke 34:1617-1622. (Pubitemid 36842613)
39. Tarlow, J. K., Blakemore, A. I., Lennard, A., Solari, R., Hughes, H. N., Steinkasserer, A., Duff, G. W. (1993). Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tanDem repeat. Hum. Genet. 91(4):403-404.
40. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., et al. Heart Disease and stroke statistics: 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-e151.
41. Touzani, O., Boutin, H., Chuquet, J., Rothwell, N. (1999). Potential mechanisms of interleukin- 1 involvement in cerebral ischaemia. J. Neuroimmunol. 100(1-2):203-215.
42. Vencovsky, J., Jarosova, K., Ruzickova, S., Nemcova, D., NieDerlova, J., Ozen, S., et al. (2001). Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile iDiopathic arthritis. Arthritis Rheum. 44:2387-2391.
43. Vila, N., Filella, X., Deulofeu, R., Ascaso, C., Abellana, R., Chamorro, A. (1999). Cytokineinduced inflammation and long-term stroke functional outcome. J. Neurol. Sci. 162:185-188.
44. Whisnant, J. P. (1997). MoDeling of risk factors for ischemic stroke. The Willis Lecture. Stroke 28:1840-1844.
45. Witkin, S. S., Gerber, S., Ledger, W. J. (2002). Influence of interleukin-1 receptor antagonist gene polymorphism on Disease. Clin. Infect. Dis. 34:204-209.
46. Worrall, B. B., Azhar, S., Nyquist, P. A., Ackerman, R. H., Hamm, T. L., DeGraba, T. J. (2003). Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34(3):790-793.